Explore UAB
UAB News Stay informed with the latest updates
Articles Tagged
News You Can Use Published more than a year ago

Most seizures occur in non-medical settings. A UAB epilepsy expert provides information on best practices to help individuals during a seizure.

Research & Innovation Published more than a year ago

While preventive treatment with vigabatrin delayed the onset and prevalence of infantile spasms in TSC infants, it had no impact on focal seizures, drug-resistant epilepsy, or improvement of cognitive and behavioral scores at 24 months.

Research & Innovation Published more than a year ago

Periodontal disease is one of the leading causes of tooth loss in adults and may be a risk factor in the development of Alzheimer’s disease.

Research & Innovation Published more than a year ago

In a mouse model, border-associated macrophages, not microglia, were essential for the neuroinflammation that precedes neurodegradation. Targeting this subset could be a disease-modifying therapy in neurodegenerative disease.

Health & Medicine Published more than a year ago

IN8bio has opened a new Birmingham facility, a 10,000-square-foot advanced research and development laboratory in the Martin Biscuit Building at Pepper Place.

Research & Innovation Published more than a year ago

The findings indicate that inflammation is present in the brain early in the disease’s progression, but how inflammation affects disease progression remains unknown.

Health & Medicine Published more than a year ago

The clinic, supported by an Alabama Department of Commerce Innovation Fund grant, makes it easier for patients to get all the services they need in one place.

Research & Innovation Published more than a year ago

The study, utilizing the relatively new field of metagenomics, demonstrated an imbalance in the gut microbiome of patients with Parkinson’s disease.

Research & Innovation Published more than a year ago

The gift will advance the use of induced pluripotent stem cells as a potential therapy for Alzheimer’s disease.

Health & Medicine Published more than a year ago

U.S. News & World report named UAB Hospital as the best hospital in Alabama.

Health & Medicine Published more than a year ago

All of the newly diagnosed glioblastoma multiforme patients enrolled in a Phase 1 clinical trial have exceeded both their median and expected progression-free survivals. Two patients, to date, have exceeded their expected overall survival.

Health & Medicine Published more than a year ago

Radiofrequency ablation precisely delivers heat energy that can destroy lesions within the brain that are the cause of seizures.

Research & Innovation Published more than a year ago

The fields of neuroengineering and brain-computer interfaces could have a tremendous impact on a number of neurologic conditions, such as stroke, neurodegenerative disorders, Parkinson’s disease, dementia and other brain diseases.

Research & Innovation Published more than a year ago

Consortium led by UAB researchers in the UAB Heersink School of Medicine and School of Public Health received additional funding to further study chronic hypertension and preeclampsia epigenetics participants enrolled in the CHAP trial.

Research & Innovation Published more than a year ago

Recent studies have shown that formal exercise training can help boost memory, and memory deficit is relatively common in people with epilepsy.

Campus & Community Published more than a year ago

Record $95 million Heersink lead gift to advance strategic growth and biomedical innovation.

Research & Innovation Published more than a year ago

Limiting neuroinflammation may represent a promising new approach to treat neurological diseases driven by neuroinflammation, such as stroke, spinal cord injury and neuropathic pain.

Research & Innovation Published more than a year ago

New results suggest the answer is no, implying that the role of tau in the pathogenesis of Lewy body dementias is distinct from Alzheimer’s disease.

Health & Medicine Published more than a year ago

Physicians treating heart disease with anti-coagulants should factor the presence of kidney disease into their decisions on medications.

Research & Innovation Published more than a year ago

The list was made by a group that aspires to bolster and increase diversity across all scientific fields, promote retention through the “leaky academic pipeline,” and broaden academic and industrial awareness of diversity and inclusion.

Back to Top